162 related articles for article (PubMed ID: 8224243)
21. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
[TBL] [Abstract][Full Text] [Related]
22. The effects of ascorbate and dehydroascorbate on the oxidation of low-density lipoprotein.
Stait SE; Leake DS
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):373-81. PubMed ID: 8973543
[TBL] [Abstract][Full Text] [Related]
23. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit.
Matthys KE; Van Hove CE; Kockx MM; Andries LJ; Van Osselaer N; Herman AG; Bult H
Cardiovasc Res; 1998 Jan; 37(1):239-46. PubMed ID: 9539879
[TBL] [Abstract][Full Text] [Related]
24. The effect of nitric oxide release rates on the oxidation of human low density lipoprotein.
Goss SP; Hogg N; Kalyanaraman B
J Biol Chem; 1997 Aug; 272(34):21647-53. PubMed ID: 9261188
[TBL] [Abstract][Full Text] [Related]
25. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
Meyer DF; Mayans MO; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
27. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
Yue TL; McKenna PJ; Lysko PG; Ruffolo RR; Feuerstein GZ
Atherosclerosis; 1992 Dec; 97(2-3):209-16. PubMed ID: 1361324
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide donors as generators and scavengers of superoxide anions.
Robak J; Gryglewski RJ
Pol J Pharmacol; 1993; 45(1):51-8. PubMed ID: 8401759
[TBL] [Abstract][Full Text] [Related]
29. Acidic pH increases the oxidation of LDL by macrophages.
Morgan J; Leake DS
FEBS Lett; 1993 Nov; 333(3):275-9. PubMed ID: 8224192
[TBL] [Abstract][Full Text] [Related]
30. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide.
Ravichandran LV; Johns RA; Rengasamy A
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2216-23. PubMed ID: 7541958
[TBL] [Abstract][Full Text] [Related]
31. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
[TBL] [Abstract][Full Text] [Related]
32. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
Dubey RK
J Pharmacol Exp Ther; 1994 Apr; 269(1):402-8. PubMed ID: 8169847
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human low density lipoprotein and high density lipoprotein oxidation by oligostilbenes from rhubarb.
Ngoc TM; Hung TM; Thuong PT; Na M; Kim H; Ha do T; Min BS; Minh PT; Bae K
Biol Pharm Bull; 2008 Sep; 31(9):1809-12. PubMed ID: 18758083
[TBL] [Abstract][Full Text] [Related]
34. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.
Megson IL; Greig IR; Gray GA; Webb DJ; Butler AR
Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806
[TBL] [Abstract][Full Text] [Related]
35. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein.
Jessup W; Mohr D; Gieseg SP; Dean RT; Stocker R
Biochim Biophys Acta; 1992 Oct; 1180(1):73-82. PubMed ID: 1327163
[TBL] [Abstract][Full Text] [Related]
36. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels.
Carrier GO; Fuchs LC; Winecoff AP; Giulumian AD; White RE
Am J Physiol; 1997 Jul; 273(1 Pt 2):H76-84. PubMed ID: 9249477
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of dacron-activated monocytic cell oxidation of low density lipoprotein.
van Aalst JA; Pitsch RJ; Absood A; Fox PL; Graham LM
J Vasc Surg; 2000 Jan; 31(1 Pt 1):171-80. PubMed ID: 10642720
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide released from zwitterionic polyamine/NO adducts inhibits Cu2+-induced low density lipoprotein oxidation.
Yamanaka N; Oda O; Nagao S
FEBS Lett; 1996 Nov; 398(1):53-6. PubMed ID: 8946952
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein.
Malo-Ranta U; Ylä-Herttuala S; Metsä-Ketelä T; Jaakkola O; Moilanen E; Vuorinen P; Nikkari T
FEBS Lett; 1994 Jan; 337(2):179-83. PubMed ID: 8287973
[TBL] [Abstract][Full Text] [Related]
40. Effects of resveratrol on oxidative modification of human low density lipoprotein.
Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
